Why So Many on BP Meds Still Miss Target
Most U.S. adults with hypertension missed blood pressure targets—including those on treatment—highlighting gaps in initiation and intensification of therapy, new JAMA data show.
By
Kathryn Wighton
February 2, 2026
Clinical Scorecard: Why So Many on BP Meds Still Miss Target
At a Glance
Category Detail
Condition Hypertension Key Mechanisms Uncontrolled blood pressure despite antihypertensive therapy. Target Population US adults with hypertension, particularly those on antihypertensive medication. Care Setting Primary care and outpatient settings.
Key Highlights
Nearly 80% of US adults with hypertension exceed recommended blood pressure thresholds. 39% of adults with uncontrolled BP were on antihypertensive medication. Adults not on medication were younger and less likely to have health insurance. Over 70% of treated adults with uncontrolled BP met high CVD risk criteria. Treatment intensification may be necessary for those already on medication. Guideline-Based Recommendations
Diagnosis
Utilize the 2025 AHA/ACC guidelines for BP targets. Management
Consider treatment intensification and combination therapy for uncontrolled BP. Monitoring & Follow-up
Regularly assess BP levels in patients on antihypertensive therapy. Risks
Patients with established CVD, diabetes, or chronic kidney disease are at higher risk. Patient & Prescribing Data
Adults with hypertension, particularly those with uncontrolled BP.
Many untreated adults could achieve BP control with medication and lifestyle changes.
Clinical Best Practices
Encourage lifestyle modifications alongside medication. Monitor for adherence and potential misclassification in self-reported medication use. References
